PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: Human Relaxin-2, Relaxin-2, Serelaxin
Human Relaxin-2 is a peptide hormone with vasodilatory and anti-fibrotic properties, also developed clinically as serelaxin. It is studied for cardiovascular and tissue-remodeling research.
Sign in to rate this peptide.
Relaxin-2 is a two-chain insulin-superfamily peptide that signals primarily through the RXFP1 G-protein-coupled receptor. Receptor activation raises cAMP and stimulates nitric-oxide and endothelin-pathway signaling, producing systemic vasodilation and increased arterial compliance. Relaxin-2 also downregulates pro-fibrotic TGF-beta signaling and activates matrix metalloproteinases, reducing collagen deposition and promoting tissue remodeling. These combined hemodynamic and anti-fibrotic actions drive its research interest in heart failure and fibrotic conditions.